Many years ago, a Japanese team did a trial using a vaccine to target SYT-SSX (the mutant gene thought to be responsible for synovial sarcoma):
http://www.ncbi.nlm.nih.gov/pubmed/15647119
Years passed and their investigations seemed to have gone nowhere or stopped. But hope is not completely lost as a new study just came out: